Skip to menu Skip to content Skip to footer
Dr Matthew Roberts
Dr

Matthew Roberts

Email: 
Phone: 
+61 7 334 66047

Overview

Background

Matthew J. Roberts, BSc, MBBS, PhD, FRACS (Urol)

  • Consultant Urologist, Royal Brisbane and Women’s (RBWH), Surgical Treatment and Rehabilitation Service (STARS), Queensland Health
  • Clinician Research Fellow, Metro North Hospital and Health Service
  • Group Leader & Associate Professor, The University of Queensland Centre for Clinical Research

Matthew is a medical graduate of The University of Queensland and completed Urology specialty training in Queensland and New South Wales. He completed his PhD under the supervision of Professor “Frank” Gardiner investigating new biomarkers for the early detection and characterization of prostate cancer.

Matthew is a surgeon-scientist, working clinically as a urologist and robotic surgeon at RBWH & STARS with academic appointment as Clinician Research Fellow at Metro North Health (Qld) and Associate Professor at UQCCR. His clinical and research interests are in Urologic cancers (e.g. prostate cancer), focusing on novel imaging and biomarkers, clinical trials, urological infections and innovation in urology. He has authored over 140 peer reviewed manuscripts in international journals and presented research at more than 20 international urology and clinical cancer meetings. He is a member of the EAU Prostate Cancer Guidelines Committee, Prostate Cancer Outcomes Registry (PCOR)-Queensland Steering Committee, Editorial Board of the BJU International, as well as Co-Convenor of the ANZUP 2024 ASM.

Availability

Dr Matthew Roberts is:
Available for supervision

Qualifications

  • Bachelor of Biomedical Science, The University of Queensland
  • Bachelor of Medicine, The University of Queensland
  • Doctor of Philosophy, The University of Queensland

Research interests

  • Urology

    All fields related to urology including urologic oncology, prostate cancer, kidney/renal cancer, bladder cancer and others. Urologic infections Quality-of-life and survivorship research Systematic review and meta-analysis.

Works

Search Professor Matthew Roberts’s works on UQ eSpace

249 works between 2000 and 2025

21 - 40 of 249 works

2024

Journal Article

ChatGPT can help guide and empower patients after prostate cancer diagnosis

Collin, Harry, Keogh, Kandice, Basto, Marnique, Loeb, Stacy and Roberts, Matthew J. (2024). ChatGPT can help guide and empower patients after prostate cancer diagnosis. Prostate Cancer and Prostatic Diseases, 1-3. doi: 10.1038/s41391-024-00864-6

ChatGPT can help guide and empower patients after prostate cancer diagnosis

2024

Journal Article

Clinical trial protocol for PRIMARY2: a multicentre, phase 3, randomised controlled trial investigating the additive diagnostic value of [68Ga]Ga-PSMA-11 positron emission tomography/computed tomography in men with negative or equivocal multiparametric magnetic resonance imaging for the diagnosis of clinically significant prostate cancer

Buteau, James P., Moon, Daniel, Fahey, Michael T., Roberts, Matthew J., Thompson, James, Murphy, Declan G., Papa, Nathan, Mitchell, Catherine, De Abreu Lourenco, Richard, Dhillon, Haryana M., Kasivisvanathan, Veeru, Francis, Roslyn J., Stricker, Phillip, Agrawal, Shihka, O'Brien, Jonathan, McVey, Aoife, Sharma, Gaurav, Levy, Sidney, Ayati, Narjess, Nguyen, Andrew, Lee, Su-Faye, Pattison, David A., Sivaratnam, Dinesh, Frydenberg, Mark, Du, Yang, Titus, Jehan, Lee, Sze-Ting, Ischia, Joseph, Jack, Greg ... Emmett, Louise (2024). Clinical trial protocol for PRIMARY2: a multicentre, phase 3, randomised controlled trial investigating the additive diagnostic value of [68Ga]Ga-PSMA-11 positron emission tomography/computed tomography in men with negative or equivocal multiparametric magnetic resonance imaging for the diagnosis of clinically significant prostate cancer. European Urology Oncology, 7 (3), 544-552. doi: 10.1016/j.euo.2023.11.008

Clinical trial protocol for PRIMARY2: a multicentre, phase 3, randomised controlled trial investigating the additive diagnostic value of [68Ga]Ga-PSMA-11 positron emission tomography/computed tomography in men with negative or equivocal multiparametric magnetic resonance imaging for the diagnosis of clinically significant prostate cancer

2024

Journal Article

Determining the optimal fill volume for fluid‐filled testicular prostheses – less is more

Mehawed, Georges, Murray, Rebecca, Wang, Kevin, Roberts, Matthew J. and Rukin, Nicholas J. (2024). Determining the optimal fill volume for fluid‐filled testicular prostheses – less is more. BJU International, 134 (S2), 14-16. doi: 10.1111/bju.16374

Determining the optimal fill volume for fluid‐filled testicular prostheses – less is more

2024

Journal Article

What to do about recurrent urinary tract infections: A review of evidence behind emerging therapies

Wynn, Jessica, Homewood, David, Tse, Vincent, Fong, Eva, Roberts, Matthew J., Chung, Eric and Dowling, Caroline (2024). What to do about recurrent urinary tract infections: A review of evidence behind emerging therapies. Australian Journal of General Practice, 53 (5), 265-273. doi: 10.31128/AJGP-10-23-7004

What to do about recurrent urinary tract infections: A review of evidence behind emerging therapies

2024

Journal Article

Prostate tumour visualisation with PET: is image fusion with MRI the answer?

Mehawed, Georges, Murray, Rebecca, Rukin, Nicholas J. and Roberts, Matthew J. (2024). Prostate tumour visualisation with PET: is image fusion with MRI the answer?. BJU International, 133 (Supplement 4), 4-6. doi: 10.1111/bju.16335

Prostate tumour visualisation with PET: is image fusion with MRI the answer?

2024

Journal Article

Exploring unmet needs in prostate cancer care: a cross-sectional descriptive study

Roberts, Natasha A., Esler, Rachel, Pearce, Adam, Wyld, David, Smith, Michael, Woollett, Kaylene, Mazariego, Carolyn and Roberts, Matthew J. (2024). Exploring unmet needs in prostate cancer care: a cross-sectional descriptive study. European Urology Open Science, 62, 36-42. doi: 10.1016/j.euros.2024.01.018

Exploring unmet needs in prostate cancer care: a cross-sectional descriptive study

2024

Journal Article

Is extended pelvic lymph node dissection REALLY required for staging of prostate cancer in the PSMA-PET era?

Roberts, Matthew J., Yaxley, John W., Stranne, Johan, van Oort, Inge M. and Tilki, Derya (2024). Is extended pelvic lymph node dissection REALLY required for staging of prostate cancer in the PSMA-PET era?. Prostate Cancer and Prostatic Diseases, 1-3. doi: 10.1038/s41391-024-00821-3

Is extended pelvic lymph node dissection REALLY required for staging of prostate cancer in the PSMA-PET era?

2024

Journal Article

Cancer‐on‐chip and integrative tumor microenvironment sensor technologies for progressing precision radiotherapy

Dey, Shuvashis, Kinoshita, Masaki, Puttick, Simon, Rose, Stephen, Trau, Matt, Roberts, Matthew J. and Koo, Kevin M. (2024). Cancer‐on‐chip and integrative tumor microenvironment sensor technologies for progressing precision radiotherapy. Advanced Sensor Research, 3 (7) 2300193. doi: 10.1002/adsr.202300193

Cancer‐on‐chip and integrative tumor microenvironment sensor technologies for progressing precision radiotherapy

2024

Conference Publication

Early oncological outcomes following radical prostatectomy of patients with pelvic lymph node-positive prostate cancer at preoperative PSMA PET/CT

Zuur, L.G., de Bie, K., Vis, A.N., Van Der Poel, H.G., Donswijk, M.L., Oprea-Lager, D.E., Roberts, M. and Van Leeuwen, P.J. (2024). Early oncological outcomes following radical prostatectomy of patients with pelvic lymph node-positive prostate cancer at preoperative PSMA PET/CT. EAU24 - 39th Annual EAU Congress, Paris, France, 5-8 April 2024. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s0302-2838(24)01187-4

Early oncological outcomes following radical prostatectomy of patients with pelvic lymph node-positive prostate cancer at preoperative PSMA PET/CT

2024

Conference Publication

Combining MRI PI-RADS and PSMA-PET/CT PRIMARY score in a composite (P) score for more accurate diagnosis of clinically significant prostate cancer

Emmett, L., Papa, N., Hope, T., Fendler, W., Calais, J., Burger, I., Eiber, M., Barbato, F., Moon, D., Xue, A., Franklin, A., Thompson, J., Rasiah, K., Frydenberg, M., Yaxley, J., Buteau, J., Liu, V., Nguyen, A., Hsiao, E., Stricker, P., Hofman, M., Kasivisvanathan, V., Roberts, M. and Murphy, D. (2024). Combining MRI PI-RADS and PSMA-PET/CT PRIMARY score in a composite (P) score for more accurate diagnosis of clinically significant prostate cancer. EAU24 - 39th Annual EAU Congress, Paris, France, 5-8 April 2024. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s0302-2838(24)00417-2

Combining MRI PI-RADS and PSMA-PET/CT PRIMARY score in a composite (P) score for more accurate diagnosis of clinically significant prostate cancer

2024

Conference Publication

Development and external validation of a novel nomogram to predict the probability of pelvic lymph-node metastases in prostate cancer patients using magnetic resonance imaging and molecular imaging with prostate-specific membrane antigen positron emission

Vis, A., Meijer, D., Roberts, M.J., Siriwardana, A.R., Morton, A., Yaxley, J.W., Samaratunga, H., Emmett, L., Van Der Ven, P.M., Heymans, M.W., Nieuwenhuijzen, J.A., Van Der Poel, H.G., Van Donswijk, M.L., Boellaard, T.N., Schoots, I.G., Stricker, P., Haynes, A-M., Oprea-Lager, D.E., Coughlin, G.D. and Van Leeuwen, P.J. (2024). Development and external validation of a novel nomogram to predict the probability of pelvic lymph-node metastases in prostate cancer patients using magnetic resonance imaging and molecular imaging with prostate-specific membrane antigen positron emission. EAU24 - 39th Annual EAU Congress, Paris, France, 5-8 April 2024. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s0302-2838(24)00422-6

Development and external validation of a novel nomogram to predict the probability of pelvic lymph-node metastases in prostate cancer patients using magnetic resonance imaging and molecular imaging with prostate-specific membrane antigen positron emission

2024

Conference Publication

The early oncological effect of extended pelvic lymph node dissection in men with at PSMA PET/CT N0M0 intermediate/high-risk prostate cancer - an international cohort study

Van Leeuwen, P.J., Berrens, A-C., Vis, A., Yaxley, J., Meijer, D., Siriwardana, A., Wit, E., Van Der Noort, V., Morton, A., Franklin, A., Yaxley, J., Wong, D., Goughlin, G., Gianduzzo, T., Kua, B., Emmett, L., Zuur, L., Van Der Poel, H. and Roberts, M. (2024). The early oncological effect of extended pelvic lymph node dissection in men with at PSMA PET/CT N0M0 intermediate/high-risk prostate cancer - an international cohort study. EAU24 - 39th Annual EAU Congress, Paris, France, 5-8 April 2024. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s0302-2838(24)01002-9

The early oncological effect of extended pelvic lymph node dissection in men with at PSMA PET/CT N0M0 intermediate/high-risk prostate cancer - an international cohort study

2024

Journal Article

The impact of management option on out-of-pocket costs and perceived financial burden among men with localised prostate cancer in Australia within 6 months of diagnosis

Lindsay, Daniel, Schofield, Penelope, Nabukalu, Doreen, Roberts, Matthew J., Yaxley, John, Quinn, Stephen, Richards, Natalie, Frydenberg, Mark, Gardiner, Robert, Lawrentschuk, Nathan, Juraskova, Ilona, Murphy, Declan G. and Gordon, Louisa G. (2024). The impact of management option on out-of-pocket costs and perceived financial burden among men with localised prostate cancer in Australia within 6 months of diagnosis. Australian Health Review, 48 (2), 172-181. doi: 10.1071/ah23231

The impact of management option on out-of-pocket costs and perceived financial burden among men with localised prostate cancer in Australia within 6 months of diagnosis

2024

Journal Article

Intra‐individual comparison of prostate‐specific membrane antigen positron emission tomography/computed tomography versus bone scan in detecting skeletal metastasis at prostate cancer diagnosis

Shanmugasundaram, Ramesh, Saad, Jeremy, Heyworth, Ash, Wong, Veronica, Pelecanos, Anita, Arianayagam, Mohan, Canagasingham, Bertram, Ferguson, Richard, Goolam, Ahmed Saeed, Khadra, Mohamed, Kam, Jonathan, Ko, Raymond, McCombie, Stephen, Varol, Celi, Winter, Matthew, Mansberg, Robert, Nguyen, Diep, Bui, Chuong, Loh, Han, Le, Ken and Roberts, Matthew J. (2024). Intra‐individual comparison of prostate‐specific membrane antigen positron emission tomography/computed tomography versus bone scan in detecting skeletal metastasis at prostate cancer diagnosis. BJU International, 133 (S3), 25-32. doi: 10.1111/bju.16115

Intra‐individual comparison of prostate‐specific membrane antigen positron emission tomography/computed tomography versus bone scan in detecting skeletal metastasis at prostate cancer diagnosis

2024

Journal Article

Guidelines for genetic testing in prostate cancer: a scoping review

Tuffaha, Haitham, Edmunds, Kim, Fairbairn, David, Roberts, Matthew J., Chambers, Suzanne, Smith, David P, Horvath, Lisa, Arora, Shiksha and Scuffham, Paul (2024). Guidelines for genetic testing in prostate cancer: a scoping review. Prostate Cancer and Prostatic Diseases, 27 (4), 594-603. doi: 10.1038/s41391-023-00676-0

Guidelines for genetic testing in prostate cancer: a scoping review

2024

Journal Article

Reproducibility and accuracy of the PRIMARY score on PSMA PET and of PI-RADS on multiparametric MRI for prostate cancer diagnosis within a real-world database

Emmett, Louise, Papa, Nathan, Counter, William, Calais, Jeremie, Barbato, Francesco, Burger, Irene, Eiber, Matthias, Roberts, Matthew J., Agrawal, Shikha, Franklin, Anthony, Xue, Alan, Rasiah, Krishan, John, Nikeith, Moon, Daniel, Frydenberg, Mark, Yaxley, John, Stricker, Phillip, Wong, Keith, Coughlin, Geoff, Gianduzzo, Troy, Kua, Boon, Ho, Bao, Nguyen, Andrew, Liu, Victor, Lee, Jonathan, Hsiao, Edward, Sutherland, Tom, Perry, Elisa, Fendler, Wolfgang P. and Hope, Thomas A. (2024). Reproducibility and accuracy of the PRIMARY score on PSMA PET and of PI-RADS on multiparametric MRI for prostate cancer diagnosis within a real-world database. Journal of Nuclear Medicine, 65 (1), 94-99. doi: 10.2967/jnumed.123.266164

Reproducibility and accuracy of the PRIMARY score on PSMA PET and of PI-RADS on multiparametric MRI for prostate cancer diagnosis within a real-world database

2024

Journal Article

Etiology and management of urethral calculi: a systematic review of contemporary series

Morton, Andrew, Tariq, Arsalan, Dunglison, Nigel, Esler, Rachel and Roberts, Matthew J. (2024). Etiology and management of urethral calculi: a systematic review of contemporary series. Asian Journal of Urology, 11 (1), 10-18. doi: 10.1016/j.ajur.2021.12.011

Etiology and management of urethral calculi: a systematic review of contemporary series

2024

Journal Article

Oncological Benefits of Extended Pelvic Lymph Node Dissection: More Fog or Clarity to the Debate?

Roberts, Matthew J., Cornford, Philip and Tilki, Derya (2024). Oncological Benefits of Extended Pelvic Lymph Node Dissection: More Fog or Clarity to the Debate?. European Urology, 87 (2), 261-263. doi: 10.1016/j.eururo.2024.12.001

Oncological Benefits of Extended Pelvic Lymph Node Dissection: More Fog or Clarity to the Debate?

2024

Journal Article

EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer. Part II—2024 update: treatment of relapsing and metastatic prostate cancer

Tilki, Derya, van den Bergh, Roderick C.N., Briers, Erik, Van den Broeck, Thomas, Brunckhorst, Oliver, Darraugh, Julie, Eberli, Daniel, De Meerleer, Gert, De Santis, Maria, Farolfi, Andrea, Gandaglia, Giorgio, Gillessen, Silke, Grivas, Nikolaos, Henry, Ann M., Lardas, Michael, J.L.H. van Leenders, Geert, Liew, Matthew, Linares Espinos, Estefania, Oldenburg, Jan, van Oort, Inge M., Oprea-Lager, Daniela E., Ploussard, Guillaume, Roberts, Matthew J., Rouvière, Olivier, Schoots, Ivo G., Schouten, Natasha, Smith, Emma J., Stranne, Johan, Wiegel, Thomas ... Cornford, Philip (2024). EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer. Part II—2024 update: treatment of relapsing and metastatic prostate cancer. European Urology, 86 (2), 164-182. doi: 10.1016/j.eururo.2024.04.010

EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer. Part II—2024 update: treatment of relapsing and metastatic prostate cancer

2024

Journal Article

The effect of three years of vitamin D supplementation on erectile dysfunction: results from the randomized placebo-controlled D-Health Trial

Romero, Briony Duarte, Waterhouse, Mary, Baxter, Catherine, McLeod, Donald S.A., English, Dallas R., Armstrong, Bruce K., Chung, Eric, Ebeling, Peter R., Hartel, Gunter, van der Pols, Jolieke C., Roberts, Matthew, Venn, Alison J., Webb, Penelope M., Whiteman, David C. and Neale, Rachel E. (2024). The effect of three years of vitamin D supplementation on erectile dysfunction: results from the randomized placebo-controlled D-Health Trial. Clinical Nutrition ESPEN, 60, 109-115. doi: 10.1016/j.clnesp.2024.01.011

The effect of three years of vitamin D supplementation on erectile dysfunction: results from the randomized placebo-controlled D-Health Trial

Funding

Current funding

  • 2024 - 2030
    Prostate Cancer - FDG - Spatial Imaging (Spatial biology meets PET imaging: A non-invasive, Google Map for Prostate cancer)
    PA Research Foundation
    Open grant

Past funding

  • 2022 - 2025
    Randomized, Double-Blind, Placebo-controlled, Multicenter Phase 3 Study to Assess the Efficacy, Safety and Immunogenicity of Vaccination With ExPEC9V in the Prevention of Invasive Extraintestinal Path
    Janssen-Cilag Pty Limited (Janssen-Cilag Australia)
    Open grant
  • 2022 - 2023
    Prospective surgeon-led trials in Prostate Cancer for personalised management and healthcare sustainability
    Viertl Clinical Investigator Award
    Open grant
  • 2021 - 2022
    De-Intensification of Post ProstatEctomy Radiotherapy (DIPPER) incorporating clinical and imaging-based risk stratification: Part 1 - Pilot study (additional site)
    ANZUP Below the Belt Research Fund
    Open grant
  • 2021
    A prospective clinical evaluation of prostate biopsy under local anaesthetic to optimise health care resources: feasibility study
    Metro North Hospital and Health Service
    Open grant
  • 2021
    Staging of aggressive prostate cancer 'invisible' to PSMA-PET: The FDG-PET for INvisible Disease (FIND) Trial
    Metro North Hospital and Health Service
    Open grant
  • 2018
    Combined TMPRSS2:ERG, PCA3 and SChLAP1 RNA in Urine for selective detection of Aggressive Prostate Cancer
    Metro North Hospital and Health Service
    Open grant
  • 2015
    Exploring new Paradigms in Pre-prostate cancer detection and management
    Royal Brisbane and Women's Hospital Foundation
    Open grant
  • 2014 - 2016
    Exploring new Paradigms in Pre-prostate cancer detection and management
    Royal Brisbane and Women's Hospital Foundation
    Open grant
  • 2013
    Optimising collection for metabonomic profiling of ejaculate to complement PCR in prostate cancer detection
    Royal Brisbane and Women's Hospital
    Open grant

Supervision

Availability

Dr Matthew Roberts is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    Roles of image fusion and 3D technology in urology: exploration and clinical integration for personalised devices

    Associate Advisor

    Other advisors: Professor Kristofer Thurecht, Dr Nick Rukin

Media

Enquiries

For media enquiries about Dr Matthew Roberts's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au